• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低血清铁与 CKD 1-4 期且转铁蛋白饱和度正常患者的贫血相关。

Low serum iron is associated with anemia in CKD stage 1-4 patients with normal transferrin saturations.

机构信息

Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou First Road, San-Ming District, Kaohsiung, 807, Taiwan.

Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

出版信息

Sci Rep. 2021 Apr 16;11(1):8343. doi: 10.1038/s41598-021-87401-w.

DOI:10.1038/s41598-021-87401-w
PMID:33863963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8052429/
Abstract

Low transferrin saturation (TSAT), calculated by serum iron divided by total iron-binding capacity (TIBC), indicates iron deficiency. Because malnutrition and inflammation are associated with low TIBC in chronic kidney disease (CKD), TSAT might not reflect iron status or risk for anemia. We examined whether low serum iron was a risk factor for anemia in CKD patients with normal TSAT. Thus we compare the risk for anemia in 2500 CKD stage 1-4 patients divided by TSAT (cutoff: 20%) and serum iron (cutoff: 70 μg/dL in men, 60 μg/dL in women). Our results confirmed low TIBC (< 200 μg/dL) was associated with hypoalbuminemia and high C-reactive protein. In fully-adjusted logistic regression, both "normal TSAT low iron" and "low TSAT low iron" groups were associated with baseline anemia (hemoglobin < 11 g/dL) (odds ratios (OR) 1.56; 95% confidence interval (CI) 1.13-2.16 and OR 2.36; 95% CI 1.76-3.18, respectively) compared with the reference group (normal TSAT normal iron). Sensitivity tests with different cutoffs for TSAT and iron also showed similar results. In patients without anemia, both groups were associated with anemia after 1 year (OR 1.69; 95% CI 1.00-2.83 and OR 1.94; 95% CI 1.11-3.40, respectively). In conclusion, CKD stage 1-4 patients with normal TSAT but low serum iron are still at risk for anemia.

摘要

转铁蛋白饱和度(TSAT)较低(通过血清铁除以总铁结合力(TIBC)计算得出)提示缺铁。由于营养不良和炎症与慢性肾脏病(CKD)中的 TIBC 降低有关,因此 TSAT 可能无法反映铁状态或贫血风险。我们研究了在 TSAT 正常(分界值:20%)和血清铁正常(男性 70μg/dL,女性 60μg/dL)的 CKD 患者中,血清铁较低是否为贫血的危险因素。因此,我们比较了 2500 名 CKD 1-4 期患者按 TSAT(分界值:20%)和血清铁(分界值:男性 70μg/dL,女性 60μg/dL)划分的贫血风险。我们的研究结果证实,TIBC 较低(<200μg/dL)与低白蛋白血症和高 C 反应蛋白相关。在完全校正的逻辑回归中,“TSAT 正常铁不足”和“TSAT 低铁不足”组与基线贫血(血红蛋白<11g/dL)相关(比值比(OR)分别为 1.56(95%置信区间(CI)为 1.13-2.16 和 2.36(95%CI 为 1.76-3.18)),与参考组(TSAT 和铁均正常)相比。TSAT 和铁的不同分界值的敏感性试验也显示出相似的结果。在无贫血的患者中,两组在 1 年后均与贫血相关(OR 分别为 1.69(95%CI 为 1.00-2.83 和 1.94(95%CI 为 1.11-3.40))。总之,TSAT 正常但血清铁较低的 CKD 1-4 期患者仍有发生贫血的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e51c/8052429/219e404628b6/41598_2021_87401_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e51c/8052429/baa784bcd66f/41598_2021_87401_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e51c/8052429/397a8396c507/41598_2021_87401_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e51c/8052429/dba0e4e03175/41598_2021_87401_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e51c/8052429/219e404628b6/41598_2021_87401_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e51c/8052429/baa784bcd66f/41598_2021_87401_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e51c/8052429/397a8396c507/41598_2021_87401_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e51c/8052429/dba0e4e03175/41598_2021_87401_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e51c/8052429/219e404628b6/41598_2021_87401_Fig4_HTML.jpg

相似文献

1
Low serum iron is associated with anemia in CKD stage 1-4 patients with normal transferrin saturations.低血清铁与 CKD 1-4 期且转铁蛋白饱和度正常患者的贫血相关。
Sci Rep. 2021 Apr 16;11(1):8343. doi: 10.1038/s41598-021-87401-w.
2
Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).血清铁调素和铁指标根据非透析慢性肾脏病患者的肾功能对贫血状态的影响不同:韩国慢性肾脏病患者结局研究(KNOW-CKD)。
Kidney Blood Press Res. 2017;42(6):1183-1192. doi: 10.1159/000485865. Epub 2017 Dec 8.
3
Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease.不同缺铁阈值与慢性肾脏病不良结局的关联
BMC Nephrol. 2018 Sep 12;19(1):225. doi: 10.1186/s12882-018-1021-3.
4
Serum total iron-binding capacity and iron status in patients with non-dialysis-dependent chronic kidney disease: A cross-sectional study in Vietnam.血清总铁结合力和非透析依赖性慢性肾脏病患者的铁状态:越南的一项横断面研究。
Asia Pac J Clin Nutr. 2020;29(1):48-54. doi: 10.6133/apjcn.202003_29(1).0007.
5
A 3-marker index improves the identification of iron disorders in CKD anaemia.一种三指标指数可改善对慢性肾脏病贫血中铁紊乱的识别。
PLoS One. 2014 Feb 19;9(2):e84144. doi: 10.1371/journal.pone.0084144. eCollection 2014.
6
Serum Biomarkers of Iron Stores Are Associated with Increased Risk of All-Cause Mortality and Cardiovascular Events in Nondialysis CKD Patients, with or without Anemia.血清铁储存生物标志物与非透析 CKD 患者(无论是否贫血)全因死亡率和心血管事件风险增加相关。
J Am Soc Nephrol. 2021 Aug;32(8):2020-2030. doi: 10.1681/ASN.2020101531. Epub 2021 Jul 8.
7
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials.透析依赖型 CKD 患者血栓栓塞事件的风险因素:四项全球罗沙司他 3 期试验的汇总分析。
Adv Ther. 2024 Apr;41(4):1553-1575. doi: 10.1007/s12325-023-02728-2. Epub 2024 Feb 16.
8
Etiological spectrum of anemia in non-dialysis-dependent chronic kidney disease: A single-center study from India.非透析依赖型慢性肾脏病贫血的病因谱:一项来自印度的单中心研究。
Saudi J Kidney Dis Transpl. 2019 Jul-Aug;30(4):932-942. doi: 10.4103/1319-2442.265471.
9
Bone marrow macrophage iron content and sideroblast count in iron- and ESA-naïve patients with CKD-related anemia.铁和 ESA 初治的慢性肾脏病相关贫血患者骨髓巨噬细胞铁含量和环形铁幼粒细胞计数。
Ren Fail. 2023 Dec;45(1):2230300. doi: 10.1080/0886022X.2023.2230300.
10
Iron Status of Cats with Chronic Kidney Disease.患有慢性肾病的猫的铁状态
J Vet Intern Med. 2015 Nov-Dec;29(6):1488-93. doi: 10.1111/jvim.13630. Epub 2015 Sep 29.

引用本文的文献

1
Regarding "Pilot pragmatic clinical trial of iron therapy in children with anemia of chronic kidney disease (FeTCh-CKD)".关于“慢性肾脏病贫血患儿铁剂治疗的实用性临床试验(FeTCh-CKD)”
Pediatr Nephrol. 2025 Sep 10. doi: 10.1007/s00467-025-06950-8.
2
Determinants of Anemia Among Patients with Chronic Kidney Disease: A Systematic Review of Empirical Evidence.慢性肾脏病患者贫血的决定因素:实证证据的系统评价
J Multidiscip Healthc. 2025 Jun 28;18:3765-3780. doi: 10.2147/JMDH.S535423. eCollection 2025.
3
The association between transferrin saturation and all-cause mortality in chronic kidney disease: findings from Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease.

本文引用的文献

1
The problem with transferrin saturation as an indicator of iron 'sufficiency' in chronic kidney disease.转铁蛋白饱和度作为慢性肾脏病中铁“充足”指标的问题。
Nephrol Dial Transplant. 2021 Jul 23;36(8):1377-1383. doi: 10.1093/ndt/gfaa048.
2
Blood pressure modifies outcomes in patients with stage 3 to 5 chronic kidney disease.血压会改变3至5期慢性肾病患者的预后。
Kidney Int. 2020 Feb;97(2):402-413. doi: 10.1016/j.kint.2019.10.021. Epub 2019 Nov 7.
3
Iron Deficiency Anemia in Chronic Kidney Disease.慢性肾脏病中的缺铁性贫血。
慢性肾脏病中转铁蛋白饱和度与全因死亡率的关联:韩国慢性肾脏病患者结局队列研究的结果
Kidney Res Clin Pract. 2024 Nov;43(6):785-796. doi: 10.23876/j.krcp.23.278. Epub 2024 May 29.
4
Clinical Experience of a Long-acting Pegylated Erythropoietin-Stimulating Agent in Pediatric Chronic Kidney Disease.长效聚乙二醇化促红细胞生成素刺激剂治疗小儿慢性肾脏病的临床经验
J Pediatr Pharmacol Ther. 2023;28(6):509-518. doi: 10.5863/1551-6776-28.6.509. Epub 2023 Oct 28.
5
The Association between Iron Deficiency and Renal Outcomes Is Modified by Sex and Anemia in Patients with Chronic Kidney Disease Stage 1-4.1-4期慢性肾脏病患者中,缺铁与肾脏结局之间的关联因性别和贫血而有所改变。
J Pers Med. 2023 Mar 14;13(3):521. doi: 10.3390/jpm13030521.
6
Association between iron status and incident coronary artery disease: a population based-cohort study.铁状态与冠心病事件的相关性:一项基于人群的队列研究。
Sci Rep. 2022 Oct 19;12(1):17490. doi: 10.1038/s41598-022-22275-0.
7
Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD.罗沙司他治疗非透析和透析依赖性慢性肾脏病贫血患者的铁状态变化。
Kidney360. 2022 Jun 29;3(9):1511-1528. doi: 10.34067/KID.0001442022. eCollection 2022 Sep 29.
8
Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology.心力衰竭中的缺铁:机制与病理生理学
J Clin Med. 2021 Dec 27;11(1):125. doi: 10.3390/jcm11010125.
Acta Haematol. 2019;142(1):44-50. doi: 10.1159/000496492. Epub 2019 Apr 10.
4
Anemia in Non-Dialysis-Dependent CKD: To Treat or Not to Treat?非透析依赖型慢性肾脏病中的贫血:治疗还是不治疗?
Am J Kidney Dis. 2019 Mar;73(3):297-299. doi: 10.1053/j.ajkd.2018.11.006. Epub 2019 Jan 5.
5
Utility of reticulocyte haemoglobin content and percentage hypochromic red cells as markers of iron deficiency anaemia among black CKD patients in South Africa.南非慢性肾脏病黑人患者中网织红细胞血红蛋白含量和低色素红细胞百分率作为缺铁性贫血标志物的效用。
PLoS One. 2018 Oct 3;13(10):e0204899. doi: 10.1371/journal.pone.0204899. eCollection 2018.
6
Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease.贫血作为全因死亡率的危险因素:慢性肾脏病的隐匿协同效应
Clin Exp Nephrol. 2018 Apr;22(2):388-394. doi: 10.1007/s10157-017-1468-8. Epub 2017 Aug 16.
7
Real-World Impact of Cardiovascular Disease and Anemia on Quality of Life and Productivity in Patients with Non-Dialysis-Dependent Chronic Kidney Disease.心血管疾病和贫血对非透析依赖型慢性肾脏病患者生活质量和生产力的现实世界影响
Adv Ther. 2017 Jul;34(7):1662-1672. doi: 10.1007/s12325-017-0566-z. Epub 2017 Jun 3.
8
Markers of iron status in chronic kidney disease.慢性肾脏病中铁状态的标志物
Hemodial Int. 2017 Jun;21 Suppl 1(Suppl 1):S21-S27. doi: 10.1111/hdi.12556. Epub 2017 Mar 22.
9
The Prevalence and Management of Anemia in Chronic Kidney Disease Patients: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).慢性肾脏病患者贫血的患病率及管理:韩国慢性肾脏病患者结局队列研究(KNOW-CKD)的结果
J Korean Med Sci. 2017 Feb;32(2):249-256. doi: 10.3346/jkms.2017.32.2.249.
10
Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: First multicenter, cross-sectional study.中国非透析慢性肾脏病患者贫血的患病率、知晓率及治疗情况:首项多中心横断面研究
Medicine (Baltimore). 2016 Jun;95(24):e3872. doi: 10.1097/MD.0000000000003872.